Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	The Angels Initiative Stroke prevention

Valvular Heart Disease

Free Subscription Articles published in Int J Cardiol Retrieve available abstracts of 251 articles: HTML format

Single Articles

July 2022
1. DILORENZO MP, DeCost G, Mai AD, Hughes N, et al
   Comparison of serum biomarkers of myocardial fibrosis with cardiac magnetic resonance in patients operated for tetralogy of Fallot.
   Int J Cardiol. 2022;358:27-33.
   PubMed     Abstract available
   
   
   
2. ALPERI A, Pascual I, Moris C, Avanzas P, et al
   New-generation Ultra and PRO devices: Latest device iterations but old valve type effects.
   Int J Cardiol. 2022;358:83-84.
   PubMed    
   
   
   
3. KIM WK, Renker M, Dorr O, Nef H, et al
   Micro-dislodgement of a self-expanding transcatheter heart valve: Incidence, predictors, and outcomes.
   Int J Cardiol. 2022;358:77-82.
   PubMed     Abstract available
   
   
   June 2022
4. RHEUDE T, Pellegrini C, Allali A, Bleiziffer S, et al
   Multicenter comparison of latest-generation balloon-expandable versus self-expanding transcatheter heart valves: Ultra versus Evolut.
   Int J Cardiol. 2022;357:115-120.
   PubMed     Abstract available
   
   
   
5. MASCIA G, Crotti L, Groppelli A, Canepa M, et al
   Syncope in hypertrophic cardiomyopathy (part I): An updated systematic review and meta-analysis.
   Int J Cardiol. 2022;357:88-94.
   PubMed     Abstract available
   
   
   May 2022
6. CASTRO-MEJIA AF, Amat-Santos I, Ortega-Armas ME, Baz JA, et al
   Development of atrioventricular and intraventricular conduction disturbances in patients undergoing transcatheter aortic valve replacement with new generation self-expanding valves: A real world multicenter analysis.
   Int J Cardiol. 2022 May 9. pii: S0167-5273(22)00665.
   PubMed     Abstract available
   
   
   
7. MATSUSHITA K, Marchandot B, Kibler M, Heger J, et al
   P2Y12 inhibition by clopidogrel increases adverse clinical events after transcatheter aortic valve replacement.
   Int J Cardiol. 2022 May 4. pii: S0167-5273(22)00583.
   PubMed     Abstract available
   
   
   
8. MONDA E, Lioncino M, Palmiero G, Franco F, et al
   Bisoprolol for treatment of symptomatic patients with obstructive hypertrophic cardiomyopathy. The BASIC (bisoprolol AS therapy in hypertrophic cardiomyopathy) study.
   Int J Cardiol. 2022;354:22-28.
   PubMed     Abstract available
   
   
   April 2022
9. SADEGHIPOUR P, Farrashi M, De Caterina R
   Response to "non-vitamin K antagonist oral anticoagulants (NOACs) in preventing thromboembolism in atrial fibrillation patients with moderate to severe mitral stenosis: Results from a pilot trial".
   Int J Cardiol. 2022 Apr 29. pii: S0167-5273(22)00637.
   PubMed    
   
   
   
10. CARBONE RG
    Advancements in calcific aortic valve disease.
    Int J Cardiol. 2022 Apr 22. pii: S0167-5273(22)00568.
    PubMed    
    
    
    
11. PANAGIDES V, Kalavrouziotis D, Dumont E, Delarochelliere R, et al
    Carotid ultrasound following Transcarotid Transcatheter aortic valve replacement.
    Int J Cardiol. 2022 Apr 22. pii: S0167-5273(22)00570.
    PubMed     Abstract available
    
    
    
12. YALCIN YC, Veenis JF, Brugts JJ, Antonides CFJ, et al
    Rate of thromboembolic and bleeding events in patients undergoing concomitant aortic valve surgery with left ventricular assist device implantation.
    Int J Cardiol. 2022 Apr 16. pii: S0167-5273(22)00555.
    PubMed     Abstract available
    
    
    
13. ZORZI A, Brunetti G, Corrado D
    Differential diagnosis between athlete's heart and hypertrophic cardiomyopathy: New pieces of the puzzle.
    Int J Cardiol. 2022;353:77-79.
    PubMed    
    
    
    
14. AUTORE C, Ferrazzi P
    Patients with hypertrophic cardiomyopathy are getting older.
    Int J Cardiol. 2022;353:73-74.
    PubMed    
    
    
    
15. BOUREAU AS, Karakachoff M, Le Scouarnec S, Capoulade R, et al
    Heritability of aortic valve stenosis and bicuspid enrichment in families with aortic valve stenosis.
    Int J Cardiol. 2022 Apr 12. pii: S0167-5273(22)00501.
    PubMed     Abstract available
    
    
    
16. KASTENGREN M, Settergren M, Ruck A, Feldt K, et al
    Percutaneous plug-based vascular closure device in 1000 consecutive transfemoral transcatheter aortic valve implantations.
    Int J Cardiol. 2022 Apr 12. pii: S0167-5273(22)00513.
    PubMed     Abstract available
    
    
    
17. JOLOBE OMP
    Characteristics of the prothrombotic milieu in mitral stenosis patients managed with direct oral anticoagulants.
    Int J Cardiol. 2022 Apr 10. pii: S0167-5273(22)00509.
    PubMed    
    
    
    
18. LI L, Dai M, Fu Y
    Non-vitamin K antagonist oral anticoagulants (NOACs) in preventing thromboembolism in atrial fibrillation patients with moderate to severe mitral stenosis: Results from a pilot trial.
    Int J Cardiol. 2022 Apr 10. pii: S0167-5273(22)00508.
    PubMed    
    
    
    
19. PANAGIDES V, Mohammadi S, Rodes-Cabau J
    Cranial nerve injury: A word of caution for transcarotid transcatheter aortic valve replacement.
    Int J Cardiol. 2022 Apr 7. pii: S0167-5273(22)00497.
    PubMed    
    
    
    
20. WEGENER A, Holm AE, Gomes LC, Lima KO, et al
    Prevalence of rheumatic heart disease in adults from the Brazilian Amazon Basin.
    Int J Cardiol. 2022;352:115-122.
    PubMed     Abstract available
    
    
    March 2022
21. GOEL A, Malik AH, Gupta R, Rawal H, et al
    Concomitant tricuspid valve repair in patients undergoing mitral valve surgery: A recent update.
    Int J Cardiol. 2022 Mar 16. pii: S0167-5273(22)00388.
    PubMed    
    
    
    
22. SADEGHIPOUR P, Pouraliakbar H, Parsaee M, Shojaeifard M, et al
    RIvaroxaban in mitral stenosis (RISE MS): A pilot randomized clinical trial.
    Int J Cardiol. 2022 Mar 16. pii: S0167-5273(22)00396.
    PubMed     Abstract available
    
    
    
23. MENNINI FS, Meucci F, Pesarini G, Vandoni P, et al
    Cost-effectiveness of transcatheter aortic valve implantation versus surgical aortic valve replacement in low surgical risk aortic stenosis patients.
    Int J Cardiol. 2022 Mar 16. pii: S0167-5273(22)00393.
    PubMed     Abstract available
    
    
    
24. MCGRATH D, Zhan Y
    Cranial nerve injury: A word of caution for transcarotid transcatheter aortic valve replacement.
    Int J Cardiol. 2022 Mar 16. pii: S0167-5273(22)00390.
    PubMed    
    
    
    
25. SANTOS-MARTINEZ S, Halim J, Castro-Mejia A, De Marco F, et al
    Myval versus alternative balloon- and self-expandable transcatheter heart valves: A central core lab analysis of conduction disturbances.
    Int J Cardiol. 2022;351:25-31.
    PubMed     Abstract available
    
    
    
26. ARGIRO A, Rosenblum H, Griffin J, Batra J, et al
    Sex related differences in exercise performance in patients with hypertrophic cardiomyopathy: Hemodynamic insights through non-invasive pressure volume analysis.
    Int J Cardiol. 2022;351:78-83.
    PubMed     Abstract available
    
    
    
27. TARASOUTCHI F, Rosa VEE
    Rivaroxaban effects on cardiac valve calcifications, renal preservation and inflammatory modulation: Have we found the panacea?
    Int J Cardiol. 2022;351:89-90.
    PubMed    
    
    
    
28. ALBUQUERQUE AM, Brophy JM
    Pacemaker risk following transcatheter aortic valve replacement - A Bayesian reanalysis.
    Int J Cardiol. 2022 Mar 11. pii: S0167-5273(22)00328.
    PubMed     Abstract available
    
    
    
29. RENKER M, Kim WK
    Assessment of frailty prior to TAVI: Can it now be measured objectively?
    Int J Cardiol. 2022;350:104-105.
    PubMed    
    
    
    
30. WERNER N, Renker M, Dorr O, Bauer T, et al
    Anatomical suitability and off-label use of contemporary transcatheter heart valves.
    Int J Cardiol. 2022;350:96-103.
    PubMed     Abstract available
    
    
    February 2022
31. LIMONGELLI G, Monda E
    Implantable cardioverter defibrillator in hypertrophic cardiomyopathy: Time to avoid unnecessary procedure.
    Int J Cardiol. 2022 Feb 22. pii: S0167-5273(22)00265.
    PubMed    
    
    
    
32. CHARITOS E, Kim WK
    Conduction disturbances following transcatheter aortic valve implantation: Any room for improvement?
    Int J Cardiol. 2022 Feb 16. pii: S0167-5273(22)00252.
    PubMed    
    
    
    
33. MASSERA D, Xia Y, Li B, Riedy K, et al
    Mitral annular calcification in hypertrophic cardiomyopathy.
    Int J Cardiol. 2022;349:83-89.
    PubMed     Abstract available
    
    
    
34. TABATA N, Tsujita K
    Disparities in transcatheter mitral valve repair - Disparities being corrected little by little?
    Int J Cardiol. 2022 Feb 14. pii: S0167-5273(22)00245.
    PubMed    
    
    
    
35. SALA A, Lorusso R, Alfieri O
    Isolated tricuspid regurgitation: A plea for early correction.
    Int J Cardiol. 2022 Feb 4. pii: S0167-5273(22)00195.
    PubMed     Abstract available
    
    
    
36. TIRADO-CONTE G, Salazar CH, McInerney A, Cruz-Utrilla A, et al
    Incidence, clinical impact and predictors of thrombocytopenia after transcatheter aortic valve replacement.
    Int J Cardiol. 2022 Feb 3. pii: S0167-5273(22)00198.
    PubMed     Abstract available
    
    
    January 2022
37. PANAGIDES V, Kalavrouziotis D, Dumont E, Delarochelliere R, et al
    Cranial nerve injury during transcarotid transcatheter aortic valve replacement.
    Int J Cardiol. 2022 Jan 31. pii: S0167-5273(22)00187.
    PubMed     Abstract available
    
    
    
38. YA'QOUB L, Alkhouli M, Elgendy IY
    Symptomatic improvement using the New York Heart Association classification as a predictor for survival after transcatheter edge-to-edge repair of the mitral valve.
    Int J Cardiol. 2022 Jan 23. pii: S0167-5273(22)00132.
    PubMed    
    
    
    
39. REDDAVID C, Costa G, Valvo R, Criscione E, et al
    Transcatheter aortic valve implantation during COVID-19 pandemic: An optimized model to relieve healthcare system overload.
    Int J Cardiol. 2022 Jan 22. pii: S0167-5273(22)00128.
    PubMed     Abstract available
    
    
    
40. ZHANG C, Liu M, Wang X, Chen S, et al
    Mechanism of CircANKRD36 regulating cell heterogeneity and endothelial mesenchymal transition in aortic valve stromal cells by regulating miR-599 and TGF-beta signaling pathway.
    Int J Cardiol. 2022 Jan 21. pii: S0167-5273(22)00134.
    PubMed     Abstract available
    
    
    
41. LECLERCQ F, Lorca L, Agullo A, Bouchdoug K, et al
    Evolution of right ventricular dysfunction and tricuspid regurgitation after TAVI: A prospective study.
    Int J Cardiol. 2022 Jan 20. pii: S0167-5273(22)00123.
    PubMed     Abstract available
    
    
    
42. HASSOUN R, Budde H, Zhazykbayeva S, Herwig M, et al
    Do they come together? Protein quality control, stress-activated signaling, and "sarcostat" in hypertrophic cardiomyopathy progression.
    Int J Cardiol. 2022;347:44-45.
    PubMed    
    
    
    
43. FUMAGALLI C, De Filippo V, Zocchi C, Tassetti L, et al
    Strength of clinical indication and therapeutic impact of the implantable cardioverter defibrillator in patients with hypertrophic cardiomyopathy.
    Int J Cardiol. 2022 Jan 11. pii: S0167-5273(22)00069.
    PubMed     Abstract available
    
    
    December 2021
44. ALPERI A, Pascual I, Moris C, Avanzas P, et al
    Valve type selection for bicuspid aortic valves in TAVR: Does the key lie in the annular size?
    Int J Cardiol. 2021 Dec 31. pii: S0167-5273(21)02049.
    PubMed    
    
    
    
45. SUDO M, Sugiura A, Treiling L, Al-Kassou B, et al
    Baseline PA/BSA ratio in patients undergoing transcatheter aortic valve replacement - A novel CT-based marker for the prediction of pulmonary hypertension and outcome.
    Int J Cardiol. 2021 Dec 16. pii: S0167-5273(21)02011.
    PubMed     Abstract available
    
    
    
46. NEGRI F, Muser D, Driussi M, Sanna GD, et al
    Prognostic role of global longitudinal strain by feature tracking in patients with hypertrophic cardiomyopathy: The STRAIN-HCM study.
    Int J Cardiol. 2021;345:61-67.
    PubMed     Abstract available
    
    
    
47. MASCIA G, Olivotto I, Brugada J, Arbelo E, et al
    Sport practice in hypertrophic cardiomyopathy: running to stand still?
    Int J Cardiol. 2021;345:77-82.
    PubMed     Abstract available
    
    
    
48. ALPERI A, Pascual I, Avanzas P, Moris C, et al
    Atrial-FMR: No longer the forgotten mechanism of functional mitral regurgitation.
    Int J Cardiol. 2021 Dec 14. pii: S0167-5273(21)01999.
    PubMed    
    
    
    
49. HEIDARI B, Ahmad A, Al-Hijji MA, Aoun J, et al
    Muscle fat index is associated with frailty and length of hospital stay following transcatheter aortic valve replacement in high-risk octogenarians.
    Int J Cardiol. 2021 Dec 3. pii: S0167-5273(21)01978.
    PubMed     Abstract available
    
    
    
50. HASSOUN R, Budde H, Zhazykbayeva S, Herwig M, et al
    Stress activated signalling impaired protein quality control pathways in human hypertrophic cardiomyopathy.
    Int J Cardiol. 2021;344:160-169.
    PubMed     Abstract available
    
    
    November 2021
51. BENFARI G, Cavalcante JL, Enriquez-Sarano M
    Multimodality imaging in functional mitral regurgitation: Valvular disease and the chamber remodeling quantification.
    Int J Cardiol. 2021 Nov 30. pii: S0167-5273(21)01955.
    PubMed    
    
    
    
52. MOSCARELLA E, Mangieri A, Giannini F, Tchetche D, et al
    Annular size and interaction with trans-catheter aortic valves for treatment of severe bicuspid aortic valve stenosis: Insights from the BEAT registry.
    Int J Cardiol. 2021 Nov 26. pii: S0167-5273(21)01871.
    PubMed     Abstract available
    
    
    
53. RUBBIO AP, Testa L, Grasso C, Sisinni A, et al
    Transcatheter edge-to-edge mitral valve repair in atrial functional mitral regurgitation insights from the multi-center MITRA-TUNE registry.
    Int J Cardiol. 2021 Nov 23. pii: S0167-5273(21)01844.
    PubMed     Abstract available
    
    
    
54. WENZL FA, Ambrosini S, Paneni F
    Molecular underpinnings of myocardial stiffness in patients with hypertrophic cardiomyopathy.
    Int J Cardiol. 2021;343:80-82.
    PubMed    
    
    
    
55. KHAN U, Shaw T, Kempny A, Gatzoulis MA, et al
    The clinical presentation and outcome of aortic coarctation associated with left ventricular inflow and outflow tract lesion in adult patients: Shone syndrome and beyond.
    Int J Cardiol. 2021;343:45-49.
    PubMed     Abstract available
    
    
    
56. PFEIFER P, Zietzer A, Holscher M, Jehle J, et al
    Transverse aortic constriction-induced heart failure leads to increased levels of circulating microparticles.
    Int J Cardiol. 2021 Nov 10. pii: S0167-5273(21)01772.
    PubMed     Abstract available
    
    
    
57. GIORDANO A, Biondi-Zoccai G, Finizio F, Ferraro P, et al
    Characteristics and outcomes of MitraClip in octogenarians: Evidence from 1853 patients in the GIOTTO registry.
    Int J Cardiol. 2021;342:65-71.
    PubMed     Abstract available
    
    
    October 2021
58. HASIN T, Mann D, Welt M, Barrett O, et al
    Loss of left ventricular rotation is a significant determinant of functional mitral regurgitation.
    Int J Cardiol. 2021 Oct 6. pii: S0167-5273(21)01509.
    PubMed     Abstract available
    
    
    
59. AL-MOHAMMAD A
    The impact of cMR on echocardiographic markers of severe aortic regurgitation, a story of synergy.
    Int J Cardiol. 2021 Oct 5. pii: S0167-5273(21)01503.
    PubMed    
    
    
    
60. BENITO-GONZALEZ T, Carrasco-Chinchilla F, Estevez-Loureiro R, Pascual I, et al
    Clinical and echocardiographic outcomes of transcatheter mitral valve repair in atrial functional mitral regurgitation.
    Int J Cardiol. 2021 Oct 2. pii: S0167-5273(21)01497.
    PubMed     Abstract available
    
    
    
61. SIONTIS KC, Liu K, Bos JM, Attia ZI, et al
    Detection of hypertrophic cardiomyopathy by an artificial intelligence electrocardiogram in children and adolescents.
    Int J Cardiol. 2021;340:42-47.
    PubMed     Abstract available
    
    
    September 2021
62. FUJITA H, Toba T, Miwa K, Suzuki M, et al
    The impact of computed tomography-derived aortic atheroma volume on prognosis after transcatheter aortic valve replacement.
    Int J Cardiol. 2021 Sep 30. pii: S0167-5273(21)01494.
    PubMed     Abstract available
    
    
    
63. GEYER M, Keller K, Tamm AR, Born S, et al
    Early symptomatic benefit indicates long-term prognosis after transcatheter mitral valve edge-to-edge repair in functional and degenerative etiology.
    Int J Cardiol. 2021 Sep 23. pii: S0167-5273(21)01479.
    PubMed     Abstract available
    
    
    
64. MONDA E, Palmiero G, Lioncino M, Rubino M, et al
    External validation of the increased wall thickness score for the diagnosis of cardiac amyloidosis.
    Int J Cardiol. 2021;339:99-101.
    PubMed     Abstract available
    
    
    
65. PAPANASTASIOU CA, Zegkos T, Kokkinidis DG, Parcharidou D, et al
    Prognostic role of left ventricular apical aneurysm in hypertrophic cardiomyopathy: A systematic review and meta-analysis.
    Int J Cardiol. 2021;339:108.
    PubMed    
    
    
    
66. EL KHOUDARY SR, Fabio A, Yester JW, Steinhauser ML, et al
    Design and rationale of a clinical trial to increase cardiomyocyte division in infants with tetralogy of Fallot.
    Int J Cardiol. 2021;339:36-42.
    PubMed     Abstract available
    
    
    
67. RODRIGUES T, Raposo SC, Brito D, Lopes LR, et al
    Prognostic relevance of exercise testing in hypertrophic cardiomyopathy. A systematic review.
    Int J Cardiol. 2021;339:83-92.
    PubMed     Abstract available
    
    
    
68. YA'QOUB L, Jneid H, Elgendy IY
    Transcatheter edge-to-edge repair of the mitral valve: A promising bridge to heart transplant for select patients?
    Int J Cardiol. 2021 Sep 9. pii: S0167-5273(21)01330.
    PubMed    
    
    
    
69. XU YP, Zhang P
    Letter on "Prognostic role of left ventricular apical aneurysm in hypertrophic cardiomyopathy: A systematic review and meta-analysis".
    Int J Cardiol. 2021;338:152.
    PubMed    
    
    
    
70. NAMDAR M, Richardot P, Johner N, Shah D, et al
    Recognition of pre-hypertrophic cardiac involvement in Fabry Disease based on automated electrocardiographic measures.
    Int J Cardiol. 2021;338:121-126.
    PubMed     Abstract available
    
    
    
71. KAWASHIMA H, Serruys PW, Mylotte D, Rosseel L, et al
    Operator preference and determinants of size selection when additional intermediate-size aortic transcatheter heart valves are made available.
    Int J Cardiol. 2021;338:168-173.
    PubMed     Abstract available
    
    
    
72. FABI M, Calicchia M, Palleri D, Ndikubwimana I, et al
    Pediatric rheumatic carditis in Italy and Rwanda: The same disease, different socio-economic settings.
    Int J Cardiol. 2021;338:154-160.
    PubMed     Abstract available
    
    
    
73. BABAPOOR-FARROKHRAN S, Pressman GS
    Mitral annular disjunction: A myocardial abnormality too?
    Int J Cardiol. 2021;338:174-175.
    PubMed    
    
    
    August 2021
74. GAO SA, Polte CL, Lagerstrand KM, Bech-Hanssen O, et al
    The usefulness of left ventricular volume and aortic diastolic flow reversal for grading chronic aortic regurgitation severity - Using cardiovascular magnetic resonance as reference.
    Int J Cardiol. 2021 Aug 30. pii: S0167-5273(21)01311.
    PubMed     Abstract available
    
    
    
75. QIN L, Chen C, Gu S, Zhou M, et al
    A radiomic approach to predict myocardial fibrosis on coronary CT angiography in hypertrophic cardiomyopathy.
    Int J Cardiol. 2021;337:113-118.
    PubMed     Abstract available
    
    
    July 2021
76. WONG I, Sondergaard L, De Backer O
    Computational simulation models to test bioprosthetic aortic valves: A valuable alternative or addition to bench testing?
    Int J Cardiol. 2021 Jul 30. pii: S0167-5273(21)01200.
    PubMed    
    
    
    
77. CATERINAA M, Andreaa R, Pompiliob F
    Aortic valve stenosis burden: Where we are now?
    Int J Cardiol. 2021 Jul 19. pii: S0167-5273(21)01177.
    PubMed    
    
    
    
78. ROBERTS-THOMSON RL, Baumann AAW, Reade J, Culgan L, et al
    Surgical and percutaneous management of Aboriginal Australians with rheumatic heart disease: Timeliness and concordance between practice and guidelines.
    Int J Cardiol. 2021;335:80-84.
    PubMed     Abstract available
    
    
    
79. HINOJAR R, Gomez AG, Garcia-Martin A, Monteagudo JM, et al
    Impact of right ventricular systolic function in patients with significant tricuspid regurgitation. A cardiac magnetic resonance study.
    Int J Cardiol. 2021 Jul 14. pii: S0167-5273(21)01168.
    PubMed     Abstract available
    
    
    
80. KAMPAKTSIS PN, Tzoumas A
    LV apical aneurysm in HCM: Implant ICD and anticoagulate?: Editorial comment on: "Prognostic role of left ventricular apical aneurysm in hypertrophic cardiomyopathy: A systematic review and meta-analysis."
    Int J Cardiol. 2021;334:86-87.
    PubMed    
    
    
    
81. WANG TKM, Kwon DH, Abou-Hassan O, Chetrit M, et al
    Strain evaluation for mitral annular disjunction by echocardiography and magnetic resonance imaging: A case-control study.
    Int J Cardiol. 2021;334:154-156.
    PubMed     Abstract available
    
    
    June 2021
82. DOLDI PM, Buech J, Orban M, Samson-Himmelstjerna P, et al
    Transcatheter mitral valve repair may increase eligibility for heart transplant listing in patients with end-stage heart failure and severe secondary mitral regurgitation.
    Int J Cardiol. 2021 Jun 19. pii: S0167-5273(21)01029.
    PubMed     Abstract available
    
    
    
83. PELLICCIA F, Pasceri V
    The less-is-better effect: The case of alcohol dose in septal ablation for hypertrophic cardiomyopathy.
    Int J Cardiol. 2021;333:143-144.
    PubMed    
    
    
    
84. MARTIN M, Junco-Vicente A, Rodriguez I
    Bicuspid aortopathy in adolescents: Another piece of the puzzle.
    Int J Cardiol. 2021;333:94-95.
    PubMed    
    
    
    
85. NARANG R, Saxena A, Ramakrishnan S, Gupta SK, et al
    An evidence-based scoring system to diagnose acute rheumatic fever with carditis in children.
    Int J Cardiol. 2021;333:146-151.
    PubMed     Abstract available
    
    
    
86. RODRIGUEZ-GABELLA T, Zimarino M, Barbanti M, Testa L, et al
    Sex based analysis of the impact of red blood cell transfusion and vascular or bleeding complications related to TAVI - The TRITAVI-Women Study.
    Int J Cardiol. 2021;333:69-76.
    PubMed     Abstract available
    
    
    
87. VESELKA J, Faber L, Liebregts M, Cooper R, et al
    Alcohol dose in septal ablation for hypertrophic obstructive cardiomyopathy.
    Int J Cardiol. 2021;333:127-132.
    PubMed     Abstract available
    
    
    
88. MOSCARELLI M, Gallo F, Gallone G, Kim WK, et al
    Aortic angle distribution and predictors of horizontal aorta in patients undergoing transcatheter aortic valve replacement.
    Int J Cardiol. 2021 Jun 6. pii: S0167-5273(21)00911.
    PubMed     Abstract available
    
    
    
89. UY J, Ketkar AG, Portnoy A, Kim JJ, et al
    Cost-utility analysis of heart surgeries for young adults with severe rheumatic mitral valve disease in India.
    Int J Cardiol. 2021 Jun 4. pii: S0167-5273(21)00916.
    PubMed     Abstract available
    
    
    
90. PAPANASTASIOU CA, Zegkos T, Karamitsos TD, Rowin EJ, et al
    Prognostic role of left ventricular apical aneurysm in hypertrophic cardiomyopathy: A systematic review and meta-analysis.
    Int J Cardiol. 2021;332:127-132.
    PubMed     Abstract available
    
    
    
91. MAGRI D, Gallo G
    Cardiopulmonary exercise testing: An increasingly important step in managing hypertrophic cardiomyopathy.
    Int J Cardiol. 2021;332:138-139.
    PubMed    
    
    
    
92. SARRAJ-ASIL A, Diez-Villanueva P
    Insight into functional tricuspid valve regurgitation pathogenesis, pathological stages, and surgical management.
    Int J Cardiol. 2021 Jun 1. pii: S0167-5273(21)00903.
    PubMed     Abstract available
    
    
    May 2021
93. VON KAPPELGAARD L, Gislason G, Davidsen M, Zwisler AD, et al
    Temporal trends and socioeconomic differences in treatment and mortality following a diagnosis of aortic stenosis.
    Int J Cardiol. 2021 May 27. pii: S0167-5273(21)00896.
    PubMed     Abstract available
    
    
    
94. WANG Z, Zhao L, He S
    Prognostic nutritional index and the risk of mortality in patients with hypertrophic cardiomyopathy.
    Int J Cardiol. 2021;331:152-157.
    PubMed     Abstract available
    
    
    
95. SEGGEWISS H, Batzner A
    Surgical myectomy in HOCM: Still gold standard for septal reduction?
    Int J Cardiol. 2021;331:174-175.
    PubMed    
    
    
    
96. TOME ESTEBAN MT
    Gender disease-dose in hypertrophic cardiomyopathy.
    Int J Cardiol. 2021;331:172-173.
    PubMed    
    
    
    
97. D'ASCENZO F, Bruno F, Baldetti L, De Filippo O, et al
    Aortic valve replacement vs. balloon-expandable and self-expandable transcatheter implantation: A network meta-analysis.
    Int J Cardiol. 2021 May 8. pii: S0167-5273(21)00811.
    PubMed     Abstract available
    
    
    
98. OOMS JF, Ceusters J, Hirsch A, Budde RPJ, et al
    Accuracy of three-dimensional computational modeling in prediction of the dynamic neo left ventricular outflow tract with transcatheter mitral valve replacement.
    Int J Cardiol. 2021 May 6. pii: S0167-5273(21)00814.
    PubMed     Abstract available
    
    
    
99. VILADES D, Garcia-Moll X, Gomez-Llorente M, Pujadas S, et al
    Differentiation of athlete's heart and hypertrophic cardiomyopathy by the fractal dimension of left ventricular trabeculae.
    Int J Cardiol. 2021;330:232-237.
    PubMed     Abstract available
    
    
    
100. MUKAI K
     Cardiac magnetic resonance T1 mapping: A novel quality assurance program paving the way towards standardization and wider clinical practice.
     Int J Cardiol. 2021;330:266-267.
     PubMed    
     
     
     
101. YAMAMURA K, Duarte V, Karur GR, Graf J, et al
     The impact of pulmonary valve replacement on pregnancy outcomes in women with tetralogy of Fallot.
     Int J Cardiol. 2021;330:43-49.
     PubMed     Abstract available
     
     
     
102. ZHANG Q, Werys K, Popescu IA, Biasiolli L, et al
     Quality assurance of quantitative cardiac T1-mapping in multicenter clinical trials - A T1 phantom program from the hypertrophic cardiomyopathy registry (HCMR) study.
     Int J Cardiol. 2021;330:251-258.
     PubMed     Abstract available
     
     
     
103. XU F, Chen Y, Tillman KA, Cui Y, et al
     Characterizing modifier genes of cardiac fibrosis phenotype in hypertrophic cardiomyopathy.
     Int J Cardiol. 2021;330:135-141.
     PubMed     Abstract available
     
     
     April 2021
104. TRIMAILLE A, Hmadeh S, Matsushita K, Schini-Kerth V, et al
     Reply to "Patients with aortic stenosis exhibit early improved endothelial function following transcatheter aortic valve replacement: The eFAST study" by Comella et al.
     Int J Cardiol. 2021 Apr 29. pii: S0167-5273(21)00747.
     PubMed    
     
     
     
105. LI C, Tang D, Yao J, Shao Y, et al
     Porcine and bovine aortic valve comparison for surgical optimization: A fluid-structure interaction modeling study.
     Int J Cardiol. 2021 Apr 28. pii: S0167-5273(21)00740.
     PubMed     Abstract available
     
     
     
106. DEKANY G, Fontos G, Satish S, Szabo G, et al
     The prognostic value of immediate post-TAVI hemodynamic evaluation is superior to aortography and transoesophageal echocardiography in predicting patient survival.
     Int J Cardiol. 2021;329:153-161.
     PubMed     Abstract available
     
     
     
107. MIDTBO H, Hauge SW, Haaverstad R, Dalen H, et al
     How reproducible is the diagnosis of borderline rheumatic heart disease?
     Int J Cardiol. 2021;328:163-164.
     PubMed    
     
     
     
108. BATZNER A, Aicha D, Pfeiffer B, Neugebauer A, et al
     Sex-related differences in symptomatic patients with hypertrophic obstructive cardiomyopathy - Time for a new definition?
     Int J Cardiol. 2021;328:117-121.
     PubMed     Abstract available
     
     
     
109. PRADEGAN N, Leon-Wyss JR, Iribarren JR, Garcia E, et al
     Contemporary trends in surgical rheumatic valve disease in a Caribbean nation.
     Int J Cardiol. 2021;328:215-217.
     PubMed     Abstract available
     
     
     
110. KHARBANDA RK, Lodder L, Ragab AAY, de Jong PL, et al
     Early and late post-operative arrhythmias after surgical myectomy: 45 years of follow-up.
     Int J Cardiol. 2021;328:63-68.
     PubMed     Abstract available
     
     
     March 2021
111. GIANNINI C, Angelillis M, Fiorina C, Tamburino C, et al
     Clinical impact and evolution of mitral regurgitation after TAVI using the new generation self-expandable valves.
     Int J Cardiol. 2021 Mar 31. pii: S0167-5273(21)00630.
     PubMed     Abstract available
     
     
     
112. DE MARZO V, Dettori S, Nicolini LA, Vercellino M, et al
     Early infections after successful transcatheter aortic valve replacement are associated with increased short- and long-term mortality: A single-center study.
     Int J Cardiol. 2021 Mar 27. pii: S0167-5273(21)00622.
     PubMed     Abstract available
     
     
     
113. OH JK, Lee SH, Lee SA, Kang DY, et al
     Prognostic impact of left ventricular mass regression after transcatheter aortic valve replacement in patients with left ventricular hypertrophy.
     Int J Cardiol. 2021 Mar 26. pii: S0167-5273(21)00557.
     PubMed     Abstract available
     
     
     
114. KIM WK, Doerr O, Renker M, Choi YH, et al
     Initial experience with a novel, modular, minimalistic approach for transfemoral aortic valve implantation.
     Int J Cardiol. 2021 Mar 26. pii: S0167-5273(21)00564.
     PubMed     Abstract available
     
     
     
115. COMELLA A, Michail M, Chan J, Cameron JD, et al
     Patients with aortic stenosis exhibit early improved endothelial function following transcatheter aortic valve replacement: The eFAST study.
     Int J Cardiol. 2021 Mar 26. pii: S0167-5273(21)00566.
     PubMed     Abstract available
     
     
     
116. LLOYD JW, Eleid MF
     Simplifying the approach to classical low-flow low-gradient severe aortic stenosis: A renewed emphasis on the resting transthoracic echocardiogram.
     Int J Cardiol. 2021 Mar 22. pii: S0167-5273(21)00547.
     PubMed    
     
     
     
117. SIURANA JM, Sabate-Rotes A, Ayerza A, Jimenez L, et al
     Adolescents with bicuspid aortic valve: Which criteria should we use for aortic dilatation?
     Int J Cardiol. 2021 Mar 20. pii: S0167-5273(21)00545.
     PubMed     Abstract available
     
     
     
118. JOSEPH N, Craft M, Mill L, Erickson CC, et al
     Assessment of mitral valve function in children and young adults with hypertrophic cardiomyopathy using three-dimensional echocardiography.
     Int J Cardiol. 2021 Mar 19. pii: S0167-5273(21)00544.
     PubMed     Abstract available
     
     
     
119. AMAT-SANTOS IJ, Barrero A
     New conduction abnormalities following aortic valve-in-valve: The weakest link of a strong chain.
     Int J Cardiol. 2021 Mar 18. pii: S0167-5273(21)00478.
     PubMed    
     
     
     
120. MANCONE M, Infusino F, Fedele F, Sardella G, et al
     Transcervical approach for TAVI: Perhaps more than a fallback.
     Int J Cardiol. 2021;327:66-67.
     PubMed    
     
     
     
121. SCOLARI FL, Faganello LS, Garbin HI, Piva E Mattos B, et al
     A systematic review of microRNAs in patients with hypertrophic cardiomyopathy.
     Int J Cardiol. 2021;327:146-154.
     PubMed     Abstract available
     
     
     
122. KOCHAV SM, Raita Y, Fifer MA, Takayama H, et al
     Predicting the development of adverse cardiac events in patients with hypertrophic cardiomyopathy using machine learning.
     Int J Cardiol. 2021;327:117-124.
     PubMed     Abstract available
     
     
     
123. BERNARD J, Tastet L, Capoulade R, Shen M, et al
     Left ventricular asymmetric remodeling and subclinical left ventricular dysfunction in patients with calcific aortic valve stenosis - Results from a subanalysis of the PROGRESSA study.
     Int J Cardiol. 2021 Mar 13. pii: S0167-5273(21)00474.
     PubMed     Abstract available
     
     
     
124. HOKKEN TW, van Wiechen MP, Ooms JF, El Azzouzi I, et al
     Impact of Interventricular membranous septum length on pacemaker need with different Transcatheter aortic valve implantation systems.
     Int J Cardiol. 2021 Mar 3. pii: S0167-5273(21)00391.
     PubMed     Abstract available
     
     
     
125. KELLERMAIR J, Saeed S, Chambers JB, Kammler J, et al
     Predictors of true-severe classical low-flow low-gradient aortic stenosis at resting echocardiography.
     Int J Cardiol. 2021 Mar 1. pii: S0167-5273(21)00381.
     PubMed     Abstract available
     
     
     February 2021
126. XIE MY, Hou LJ
     LncRNA MALAT1 aggravates calcific aortic valve disease by sponging miR-195.
     Int J Cardiol. 2021 Feb 26. pii: S0167-5273(21)00370.
     PubMed    
     
     
     
127. KRALER S, Wenzl FA, Akhmedov A, Blaser MC, et al
     ApoA-I mimetics improve aortic stenosis-associated left-ventricular diastolic dysfunction but fail to benefit rabbit models with normal aortic valves.
     Int J Cardiol. 2021 Feb 21. pii: S0167-5273(21)00297.
     PubMed    
     
     
     
128. AKODAD M, Aldhaheri E, Marin G, Roubille F, et al
     Transcatheter aortic valve replacement performed with selective telemetry monitoring: A prospective study.
     Int J Cardiol. 2021 Feb 20. pii: S0167-5273(21)00281.
     PubMed     Abstract available
     
     
     
129. TENGLER A, Ulrich S, Fischer M, Pastor-Villaescusa B, et al
     Rationale and feasibility of transcatheter pulmonary valve implantation in small conduits with the Edwards Sapien valves.
     Int J Cardiol. 2021;325:45-50.
     PubMed     Abstract available
     
     
     
130. STANKOWSKI T, Mangner N, Linke A, Aboul-Hassan SS, et al
     Cardiac conduction abnormalities in patients with degenerated bioprostheses undergoing transcatheter aortic valve-in-valve implantations and their impact on long-term outcomes.
     Int J Cardiol. 2021 Feb 13. pii: S0167-5273(21)00282.
     PubMed     Abstract available
     
     
     
131. FIDOCK B, Archer G, Barker N, Elhawaz A, et al
     Standard and emerging CMR methods for mitral regurgitation quantification.
     Int J Cardiol. 2021 Feb 3. pii: S0167-5273(21)00148.
     PubMed     Abstract available
     
     
     January 2021
132. WANG H, Song H, Yang Y, Wu Z, et al
     Morphology display and hemodynamic testing using 3D printing may aid in the prediction of LVOT obstruction after mitral valve replacement.
     Int J Cardiol. 2021 Jan 31. pii: S0167-5273(21)00110.
     PubMed     Abstract available
     
     
     
133. LUQUE T, Noriega FJ, McInerney A, Travieso A, et al
     Impact of delirium in acute cardiac care unit after transcatheter aortic valve replacement.
     Int J Cardiol. 2021 Jan 30. pii: S0167-5273(21)00135.
     PubMed     Abstract available
     
     
     
134. REIFART J, Liebetrau C, Weferling M, Dorr O, et al
     Single versus double use of a suture-based closure device for transfemoral aortic valve implantation.
     Int J Cardiol. 2021 Jan 30. pii: S0167-5273(21)00125.
     PubMed     Abstract available
     
     
     
135. ANDO T, Onishi T, Tobaru T
     Extremely severe aortic stenosis - Is TAVR the answer?
     Int J Cardiol. 2021 Jan 28. pii: S0167-5273(21)00085.
     PubMed    
     
     
     
136. VALLABHAJOSYULA S, Vallabhajosyula S, Yang LT, Rabinstein AA, et al
     Frequency of intracranial aneurysms and sub-arachnoid hemorrhage is significantly lesser in bicuspid aortic valve than aortic coarctation.
     Int J Cardiol. 2021 Jan 28. pii: S0167-5273(21)00127.
     PubMed     Abstract available
     
     
     
137. KOFFLARD MJM
     Pacing in hypertrophic obstructive cardiomyopathy: First choice therapy in low volume centers?
     Int J Cardiol. 2021;323:199-200.
     PubMed    
     
     
     
138. DORSCH LM, Kuster DWD, Jongbloed JDH, Boven LG, et al
     The effect of tropomyosin variants on cardiomyocyte function and structure that underlie different clinical cardiomyopathy phenotypes.
     Int J Cardiol. 2021;323:251-258.
     PubMed     Abstract available
     
     
     
139. HUURMAN R, Schinkel AFL, de Jong PL, van Slegtenhorst MA, et al
     Impact of sex on timing and clinical outcome of septal myectomy for obstructive hypertrophic cardiomyopathy.
     Int J Cardiol. 2021;323:133-139.
     PubMed     Abstract available
     
     
     
140. KONECNY T, Khoo M, Covassin N, Edelhofer P, et al
     Increased heart rate with sleep disordered breathing in hypertrophic cardiomyopathy.
     Int J Cardiol. 2021;323:155-160.
     PubMed     Abstract available
     
     
     
141. NACHAR W, Merlet N, Maafi F, Mihalache-Avram T, et al
     ApoA-I mimetic does not improve left ventricular diastolic dysfunction in rabbits without aortic valve stenosis.
     Int J Cardiol. 2021 Jan 6. pii: S0167-5273(20)34337.
     PubMed     Abstract available
     
     
     
142. SAJI M, Higuchi R, Izumi Y, Takamisawa I, et al
     Transcatheter aortic valve replacement in patients with extremely severe aortic stenosis.
     Int J Cardiol. 2021 Jan 5. pii: S0167-5273(20)34328.
     PubMed     Abstract available
     
     
     
143. MICELI A, Di Bacco L, Donatelli F, Glauber M, et al
     Can we solve two problems with a TAVR?
     Int J Cardiol. 2021;322:95-96.
     PubMed    
     
     
     
144. JAVIDGONBADI D, Andersson B, Abdon NJ, Ostman-Smith I, et al
     Morbidity and resource usage after myectomy- or pacing-treatment in hypertrophic obstructive cardiomyopathy: A case-control study.
     Int J Cardiol. 2021;322:197-203.
     PubMed     Abstract available
     
     
     
145. RYU AJ, Kumar V, Borlaug BA, Manduca A, et al
     Systolic-to-diastolic myocardial volume ratio as a novel imaging marker of cardiomyopathy.
     Int J Cardiol. 2021;322:272-277.
     PubMed     Abstract available
     
     
     December 2020
146. IACOVELLI F, Pignatelli A, Cafaro A, Stabile E, et al
     Impact of contrast medium osmolality on the risk of acute kidney injury after transcatheter aortic valve implantation: Insights from the magna Graecia TAVI registry.
     Int J Cardiol. 2020 Dec 23. pii: S0167-5273(20)34297.
     PubMed     Abstract available
     
     
     
147. KHERALLAH RY, Harrison D, Preventza O, Silva GV, et al
     Transcatheter aortic valve replacement after chest radiation: A propensity-matched analysis.
     Int J Cardiol. 2020 Dec 22. pii: S0167-5273(20)34302.
     PubMed     Abstract available
     
     
     
148. USUKU H, Yamamoto E, Noguchi M, Komorita T, et al
     Elevated C-reactive protein is significantly associated with left ventricular dysfunction in patients with aortic regurgitation and concomitant collagen disease.
     Int J Cardiol. 2020 Dec 22. pii: S0167-5273(20)34301.
     PubMed     Abstract available
     
     
     
149. ALI FM, Ong G, Edwards J, Connelly KA, et al
     Comparison of transcatheter tricuspid valve repair using the MitraClip NTR and XTR systems.
     Int J Cardiol. 2020 Dec 7. pii: S0167-5273(20)34244.
     PubMed     Abstract available
     
     
     
150. TRIPATHI B, Sawant AC, Sharma P, Tandon V, et al
     Short term outcomes after transcatheter mitral valve repair.
     Int J Cardiol. 2020 Dec 2. pii: S0167-5273(20)34219.
     PubMed     Abstract available
     
     
     November 2020
151. PASCANER AF, Houriez-Gombaud-Saintonge S, Craiem D, Gencer U, et al
     Comprehensive assessment of local and regional aortic stiffness in patients with tricuspid or bicuspid aortic valve aortopathy using magnetic resonance imaging.
     Int J Cardiol. 2020 Nov 28. pii: S0167-5273(20)34169.
     PubMed     Abstract available
     
     
     
152. LU H, Monney P, Fournier S, Pavon AG, et al
     Transcervical approach versus transfemoral approach for transcatheter aortic valve replacement.
     Int J Cardiol. 2020 Nov 23. pii: S0167-5273(20)34149.
     PubMed     Abstract available
     
     
     
153. CHENG YY, Chow V, Brieger D, Yan TD, et al
     Outcomes of 16,436 patients requiring isolated aortic valve surgery: A statewide cohort study.
     Int J Cardiol. 2020 Nov 9. pii: S0167-5273(20)34084.
     PubMed     Abstract available
     
     
     
154. MONDA E, Limongelli G
     The hospitalizations in hypertrophic cardiomyopathy: "The dark side of the moon".
     Int J Cardiol. 2020;318:101-102.
     PubMed    
     
     
     
155. MAOR E, Barbash IM
     TAVR review of reviews: A new view on the horizon.
     Int J Cardiol. 2020;318:43-44.
     PubMed    
     
     
     October 2020
156. IELASI A, Moscarella E, Mangieri A, Giannini F, et al
     Procedural and clinical outcomes of type 0 versus type 1 bicuspid aortic valve stenosis undergoing trans-catheter valve replacement with new generation devices: Insight from the BEAT international collaborative registry.
     Int J Cardiol. 2020 Oct 22. pii: S0167-5273(20)34003.
     PubMed     Abstract available
     
     
     
157. ANDO T, Adegbala O, Aggarwal A, Afonso L, et al
     Redo aortic valve intervention after transcatheter aortic valve replacement: Analysis of the nationwide readmission database.
     Int J Cardiol. 2020 Oct 22. pii: S0167-5273(20)33991.
     PubMed     Abstract available
     
     
     
158. ZHANG Y, Fan P, Zhang H, Ma W, et al
     Clinical characteristics and outcomes of chronic heart failure in adult Takayasu arteritis: A cohort study of 163 patients.
     Int J Cardiol. 2020 Oct 18. pii: S0167-5273(20)33984.
     PubMed     Abstract available
     
     
     
159. LESSICK J
     Is CMR the gold standard for evaluating transvalvular flow?
     Int J Cardiol. 2020;317:221-222.
     PubMed    
     
     
     
160. JENSEN JK, Poulsen SH
     Left atrial systolic function by strain analysis - A new useful prognostic tool in primary severe mitral regurgitation?
     Int J Cardiol. 2020 Oct 6. pii: S0167-5273(20)33911.
     PubMed    
     
     
     
161. YILDIRIM OT, Ozgeyik M, Ozgeyik MO
     Safety of transcatheter aortic valve replacement at malignancy patients.
     Int J Cardiol. 2020 Oct 4. pii: S0167-5273(20)33907.
     PubMed    
     
     
     September 2020
162. SUN W, Qu L
     Upregulation of microRNA-195 might be a novel therapeutic target in the treatment of aortic valve calcification.
     Int J Cardiol. 2020 Sep 10. pii: S0167-5273(20)33803.
     PubMed    
     
     
     
163. MANDOLI GE, Pastore MC, Benfari G, Bisleri G, et al
     Left atrial strain as a pre-operative prognostic marker for patients with severe mitral regurgitation.
     Int J Cardiol. 2020 Sep 10. pii: S0167-5273(20)33743.
     PubMed     Abstract available
     
     
     
164. RONG LQ, Hameed I, Di Franco A, Rahouma MM, et al
     A pairwise meta-analytic comparison of aortic valve area determined by planimetric versus hemodynamic methods in aortic stenosis.
     Int J Cardiol. 2020 Sep 8. pii: S0167-5273(20)33737.
     PubMed     Abstract available
     
     
     
165. CHASAPI A, Karogiannis N, Zidros S, Patel K, et al
     Determinants of outcome in patients with heart failure with reduced ejection fraction & secondary mitral regurgitation.
     Int J Cardiol. 2020 Sep 7. pii: S0167-5273(20)33731.
     PubMed     Abstract available
     
     
     August 2020
166. GILL C, Lee M, Balanescu DV, Donisan T, et al
     Transcatheter and Surgical Aortic Valve Replacement Impact on Outcomes and Cancer Treatment Schedule.
     Int J Cardiol. 2020 Aug 25. pii: S0167-5273(20)33654.
     PubMed     Abstract available
     
     
     
167. MORELLO A, Corcione N, Ferraro P, Cimmino M, et al
     The best way to transcatheter aortic valve implantation: From standard to new approaches.
     Int J Cardiol. 2020 Aug 16. pii: S0167-5273(20)33563.
     PubMed     Abstract available
     
     
     
168. GOEL R, Sartori S, Cao D, Claessen BE, et al
     Impact of diabetes mellitus on female subjects undergoing transcatheter aortic valve implantation: Insights from the WIN-TAVI international registry.
     Int J Cardiol. 2020 Aug 16. pii: S0167-5273(20)33562.
     PubMed     Abstract available
     
     
     
169. TERENTES-PRINTZIOS D, Gardikioti V, Aznaouridis K, Latsios G, et al
     The impact of transcatheter aortic valve implantation on arterial stiffness and wave reflections.
     Int J Cardiol. 2020 Aug 13. pii: S0167-5273(20)33567.
     PubMed     Abstract available
     
     
     
170. EDWARDS KS, Chow EKH, Dao C, Hossepian D, et al
     Impact of cognitive behavioral therapy on depression symptoms after transcatheter aortic valve replacement: A randomized controlled trial.
     Int J Cardiol. 2020 Aug 12. pii: S0167-5273(20)33534.
     PubMed     Abstract available
     
     
     
171. FREA S, Pidello S, Boretto P, Rettegno S, et al
     Disproportionate functional mitral regurgitation predicts a favourable response after MitraClip implant in patients with advanced heart failure. Real-world evidence of a new conceptual framework.
     Int J Cardiol. 2020 Aug 11. pii: S0167-5273(20)33553.
     PubMed     Abstract available
     
     
     July 2020
172. CAI S, Bowers N, Dhoot A, Ho EC, et al
     Natural history of severe tricuspid regurgitation: Outcomes after transcatheter tricuspid valve intervention compared to medical therapy.
     Int J Cardiol. 2020 Jul 16. pii: S0167-5273(20)33466.
     PubMed     Abstract available
     
     
     
173. GOETTE A
     Atrial functional mitral regurgitation: A relavant factor for fibrillatory atrial cardiomyopathy prognosis?
     Int J Cardiol. 2020 Jul 15. pii: S0167-5273(20)33460.
     PubMed    
     
     
     
174. REDDY SC, Zhang J, Jani V, Wolfe SB, et al
     Left ventricular myocardial deformation as measure of hemodynamic burden in congenital valvular aortic stenosis.
     Int J Cardiol. 2020 Jul 14. pii: S0167-5273(20)33456.
     PubMed     Abstract available
     
     
     
175. ORBAN M, Orban M, Hausleiter J, Braun D, et al
     Tricuspid regurgitation and right ventricular dysfunction after cardiac device implantation - Is it time for intra-procedural TEE-guided lead implantation?
     Int J Cardiol. 2020 Jul 13. pii: S0167-5273(20)33458.
     PubMed    
     
     
     
176. COMPAGNONE M, Marchetti G, Taglieri N, Ghetti G, et al
     Long-term outcome of prosthesis-patient mismatch after transcatheter aortic valve replacement.
     Int J Cardiol. 2020 Jul 5. pii: S0167-5273(20)33411.
     PubMed     Abstract available
     
     
     
177. LU F, Qiao F, Lv Y, An Z, et al
     A radial force-independent bioprosthesis for transcatheter tricuspid valve implantation in a preclinical model.
     Int J Cardiol. 2020 Jul 4. pii: S0167-5273(20)33448.
     PubMed     Abstract available
     
     
     June 2020
178. KIM K, Kitai T, Kaji S, Pak M, et al
     Outcomes and predictors of cardiac events in medically treated patients with atrial functional mitral regurgitation.
     Int J Cardiol. 2020 Jun 28. pii: S0167-5273(20)33420.
     PubMed     Abstract available
     
     
     
179. ANDELL P, Li X, Martinsson A, Nilsson PM, et al
     Neighborhood socioeconomic status and aortic stenosis: A Swedish study based on nationwide registries and an echocardiographic screening cohort.
     Int J Cardiol. 2020 Jun 28. pii: S0167-5273(20)33412.
     PubMed     Abstract available
     
     
     
180. KAVSUR R, Hupp H, Sugiura A, Ozturk C, et al
     Pulmonary capillary wedge pressure (PCWP) as prognostic indicator in patients undergoing transcatheter valve repair (TTVR) of severe tricuspid regurgitation.
     Int J Cardiol. 2020 Jun 26. pii: S0167-5273(20)33409.
     PubMed     Abstract available
     
     
     
181. MATHEW J, Nguyen A, Nishimura RA, Geske JB, et al
     Septal Myectomy in patients with previous coronary revascularization - hypertrophic cardiomyopathy masquerading as ischemic heart disease.
     Int J Cardiol. 2020 Jun 19. pii: S0167-5273(20)33393.
     PubMed     Abstract available
     
     
     
182. SAEED S, Smith J, Grigoryan K, Lysne V, et al
     The tricuspid annular plane systolic excursion to systolic pulmonary artery pressure index: Association with all-cause mortality in patients with moderate or severe tricuspid regurgitation.
     Int J Cardiol. 2020 Jun 5. pii: S0167-5273(20)31030.
     PubMed     Abstract available
     
     
     
183. RUBINO AS, Torella M, Della Ratta EE, Galbiati D, et al
     Safety of low intensity oral anticoagulant therapy in patients with bileaflet mechanical aortic valve prosthesis: A propensity weighted study.
     Int J Cardiol. 2020 Jun 5. pii: S0167-5273(20)30777.
     PubMed     Abstract available
     
     
     
184. SCARSINI R, Lunardi M, Venturi G, Pighi M, et al
     Long-term variations of FFR and iFR after transcatheter aortic valve implantation.
     Int J Cardiol. 2020 Jun 3. pii: S0167-5273(20)31098.
     PubMed     Abstract available
     
     
     
185. KHAN M, Senguttuvan NB, Krishnamoorthy P, Vengrenyuk Y, et al
     Coronary angiography and percutaneous coronary intervention after transcatheter aortic valve replacement with medtronic self-expanding prosthesis: Insights from correlations with computer tomography.
     Int J Cardiol. 2020 Jun 1. pii: S0167-5273(20)32198.
     PubMed     Abstract available
     
     
     May 2020
186. GUTIERREZ E, Martinez-Legazpi P, Bermejo J
     Hard events, stiff valves, stiff arteries and stiff ventricles: the complex interactions of degenerative aortic valve stenosis.
     Int J Cardiol. 2020 May 30. pii: S0167-5273(20)31686.
     PubMed    
     
     
     
187. IANNOPOLLO G, Romano V, Buzzatti N, Ancona M, et al
     Supra-annular sizing of transcatheter aortic valve prostheses in raphe-type bicuspid aortic valve disease: The LIRA method.
     Int J Cardiol. 2020 May 27. pii: S0167-5273(20)33067.
     PubMed     Abstract available
     
     
     
188. ILIADIS C, Metze C, Korber MI, Baldus S, et al
     Impact of COAPT trial exclusion criteria in real-world patients undergoing transcatheter mitral valve repair.
     Int J Cardiol. 2020 May 26. pii: S0167-5273(19)36336.
     PubMed     Abstract available
     
     
     
189. PAPAGEORGIOU N, Falconer D, Wyeth N, Lloyd G, et al
     Effect of tricuspid regurgitation and right ventricular dysfunction on long-term mortality in patients undergoing cardiac devices implantation: >10-year follow-up study.
     Int J Cardiol. 2020 May 26. pii: S0167-5273(20)30403.
     PubMed     Abstract available
     
     
     
190. AL-FARRA H, Abu-Hanna A, de Mol BAJM, Ter Burg WJ, et al
     External validation of existing prediction models of 30-day mortality after Transcatheter Aortic Valve Implantation (TAVI) in the Netherlands Heart Registration.
     Int J Cardiol. 2020 May 22. pii: S0167-5273(19)36171.
     PubMed     Abstract available
     
     
     
191. WERNLY B, Muessig J, Lichtenauer M, Rouet P, et al
     Reply to: In searching for prognostic markers in transcatheter aortic valve replacement: Diastolic dysfunction and insulin-like growth factor system assessment.
     Int J Cardiol. 2020;307:136.
     PubMed    
     
     
     
192. PFLUECKE C, Wydra S, Berndt K, Tarnowski D, et al
     Mon2-monocytes and increased CD-11b expression before transcatheter aortic valve implantation are associated with earlier death.
     Int J Cardiol. 2020 May 12. pii: S0167-5273(20)30913.
     PubMed     Abstract available
     
     
     
193. WESTREICH R, Abramowitz Y
     Cancer in patients with severe aortic stenosis undergoing transcatheter aortic valve replacement: Is it malignant or benign?
     Int J Cardiol. 2020 May 11. pii: S0167-5273(20)31336.
     PubMed    
     
     
     
194. DURAN KARADUMAN B, Ayhan H, Keles T, Bozkurt E, et al
     The playmaker of the mitral valve disease: Mitral annulus.
     Int J Cardiol. 2020 May 5. pii: S0167-5273(20)31547.
     PubMed    
     
     
     
195. ZELIS JM, Meiburg R, Roijen J, Janssens KLPM, et al
     3D-printed stenotic aortic valve model to simulate physiology before, during, and after transcatheter aortic valve implantation.
     Int J Cardiol. 2020 May 4. pii: S0167-5273(20)30219.
     PubMed     Abstract available
     
     
     April 2020
196. OZCINAR E
     Minimal invasive approach in mitral valve surgery: Evolving method which requires higher experience and skills.
     Int J Cardiol. 2020 Apr 17. pii: S0167-5273(20)31891.
     PubMed    
     
     
     
197. FREITAS-FERRAZ AB, Nombela-Franco L, Urena M, Maes F, et al
     Transcatheter aortic valve replacement in patients with paradoxical low-flow, low-gradient aortic stenosis: Incidence and predictors of treatment futility.
     Int J Cardiol. 2020 Apr 13. pii: S0167-5273(20)31055.
     PubMed     Abstract available
     
     
     
198. MC MORROW R, Kriza C, Urban P, Amenta V, et al
     Assessing the safety and efficacy of TAVR compared to SAVR in low-to-intermediate surgical risk patients with aortic valve stenosis: An overview of reviews.
     Int J Cardiol. 2020 Apr 11. pii: S0167-5273(19)35904.
     PubMed     Abstract available
     
     
     
199. SAEED S, Saeed N, Grigoryan K, Chowienczyk P, et al
     Determinants and clinical significance of aortic stiffness in patients with moderate or severe aortic stenosis.
     Int J Cardiol. 2020 Apr 2. pii: S0167-5273(19)36394.
     PubMed     Abstract available
     
     
     
200. CHEN Y, O'Mahony C
     The price and value of implantable cardioverter defibrillators in hypertrophic cardiomyopathy.
     Int J Cardiol. 2020 Apr 2. pii: S0167-5273(20)30939.
     PubMed    
     
     
     
201. WEBER L, Rickli H, Ammann P, Taramasso M, et al
     Hemodynamic profile of patients with severe aortic valve stenosis and atrial fibrillation versus sinus rhythm.
     Int J Cardiol. 2020 Apr 1. pii: S0167-5273(19)35939.
     PubMed     Abstract available
     
     
     March 2020
202. GAVAZZONI M, Taramasso M, Zuber M, Pozzoli A, et al
     Functional mitral regurgitation and cardiac resynchronization therapy in the "era" of trans-catheter interventions: Is it time to move from a staged strategy to a tailored therapy?
     Int J Cardiol. 2020 Mar 28. pii: S0167-5273(19)35293.
     PubMed     Abstract available
     
     
     
203. SOLER M, Minana G, Santas E, Nunez E, et al
     CA125 outperforms NT-proBNP in acute heart failure with severe tricuspid regurgitation.
     Int J Cardiol. 2020 Mar 21. pii: S0167-5273(19)35557.
     PubMed     Abstract available
     
     
     
204. MYAT A, Papachristofi O, Trivedi U, Bapat V, et al
     Transcatheter aortic valve implantation via surgical subclavian versus direct aortic access: A United Kingdom analysis.
     Int J Cardiol. 2020 Mar 21. pii: S0167-5273(19)36135.
     PubMed     Abstract available
     
     
     
205. BAZ L, Wiesel M, Mobius-Winkler S, Westphal JG, et al
     Depression and anxiety in elderly patients with severe symptomatic aortic stenosis persistently improves after transcatheter aortic valve replacement (TAVR).
     Int J Cardiol. 2020 Mar 18. pii: S0167-5273(19)36351.
     PubMed     Abstract available
     
     
     
206. BIANCARI F, Dahlbacka S, Juvonen T, Virtanen MPO, et al
     Favorable outcome of cancer patients undergoing transcatheter aortic valve replacement.
     Int J Cardiol. 2020 Mar 18. pii: S0167-5273(19)35546.
     PubMed     Abstract available
     
     
     
207. BALISTRERI CR
     To the research of treatments for the typical calcific disease of old aortic valve in the omics era: Is the miR-195 a therapeutic signature via targetable p38-MAPK/VWF axis in bicuspid aortic valve?
     Int J Cardiol. 2020 Mar 16. pii: S0167-5273(20)30509.
     PubMed    
     
     
     
208. IMAMURA T
     Worsening of mitral regurgitation following transcatheter aortic valve replacement.
     Int J Cardiol. 2020;303:22.
     PubMed    
     
     
     February 2020
209. DEHGHANI P, Singer Z, Morrison J, Booker J, et al
     Characteristics and usefulness of unintended premature ventricular contraction during invasive assessment of aortic stenosis.
     Int J Cardiol. 2020 Feb 28. pii: S0167-5273(20)30202.
     PubMed     Abstract available
     
     
     
210. KALOGERAS K, Ruparelia N, Kabir T, Jabbour R, et al
     Comparison of the self-expanding Evolut-PRO transcatheter aortic valve to its predecessor Evolut-R in the real world multicenter ATLAS registry.
     Int J Cardiol. 2020 Feb 27. pii: S0167-5273(19)34112.
     PubMed     Abstract available
     
     
     
211. KAUW D, Woudstra OI, van Engelen K, Meijboom FJ, et al
     22q11.2 deletion syndrome is associated with increased mortality in adults with tetralogy of Fallot and pulmonary atresia with ventricular septal defect.
     Int J Cardiol. 2020 Feb 27. pii: S0167-5273(19)35419.
     PubMed     Abstract available
     
     
     
212. MICALI LR, Parise G, Moula AI, Alayed Y, et al
     Are recurrence of ischemic mitral regurgitation and left ventricular reverse remodeling after restrictive annuloplasty ring dependent?
     Int J Cardiol. 2020 Feb 27. pii: S0167-5273(19)34381.
     PubMed     Abstract available
     
     
     
213. MAGNUSSON P, Wimo A
     Health economic evaluation of implantable cardioverter defibrillators in hypertrophic cardiomyopathy in adults.
     Int J Cardiol. 2020 Feb 20. pii: S0167-5273(19)35600.
     PubMed     Abstract available
     
     
     
214. GUIMARAES L, Ferreira-Neto AN, Urena M, Nombela-Franco L, et al
     Transcatheter aortic valve replacement with the balloon-expandable SAPIEN 3 valve: Impact of calcium score on valve performance and clinical outcomes.
     Int J Cardiol. 2020 Feb 19. pii: S0167-5273(19)35596.
     PubMed     Abstract available
     
     
     
215. WATANABE Y, Nara Y, Hioki H, Kawashima H, et al
     Short-term effects of low-dose tolvaptan in acute decompensated heart failure patients with severe aortic stenosis: The LOHAS registry.
     Int J Cardiol. 2020 Feb 7. pii: S0167-5273(19)34524.
     PubMed     Abstract available
     
     
     
216. LENIHAN DJ, Jimenez J
     Cardiac amyloidosis and hypertrophic cardiomyopathy: "You always have time to make an accurate diagnosis!"
     Int J Cardiol. 2020;300:205-206.
     PubMed    
     
     
     
217. KALBACHER D, Daubmann A, Tigges E, Hunlich M, et al
     Impact f pre- and post-procedural renal dysfunction on long-term outcomes in patients undergoing MitraClip implantation: A retrospective analysis from two German high-volume centres.
     Int J Cardiol. 2020;300:87-92.
     PubMed    
     
     
     
218. MAURIZI N, Rella V, Fumagalli C, Salerno S, et al
     Prevalence of cardiac amyloidosis among adult patients referred to tertiary centres with an initial diagnosis of hypertrophic cardiomyopathy.
     Int J Cardiol. 2020;300:191-195.
     PubMed     Abstract available
     
     
     January 2020
219. COISNE A, Ninni S, Pontana F, Aghezzaf S, et al
     Clinical significance of electrocardiographic markers of myocardial damage prior to aortic valve replacement.
     Int J Cardiol. 2020 Jan 29. pii: S0167-5273(19)33328.
     PubMed     Abstract available
     
     
     
220. KIM K, Furukawa Y
     Sex-related differences in the response to exercise testing in asymptomatic aortic stenosis.
     Int J Cardiol. 2020 Jan 22. pii: S0167-5273(19)35899.
     PubMed    
     
     
     
221. BERKOVITCH A, Barbash IM, Finkelstein A, Assali AR, et al
     Validation of cardiac damage classification and addition of albumin in a large cohort of patients undergoing transcatheter aortic valve replacement.
     Int J Cardiol. 2020 Jan 15. pii: S0167-5273(19)34869.
     PubMed     Abstract available
     
     
     
222. YANG H, Bouma BJ, Dimopoulos K, Khairy P, et al
     Non-vitamin K antagonist oral anticoagulants (NOACs) for thromboembolic prevention, are they safe in congenital heart disease? Results of a worldwide study.
     Int J Cardiol. 2020;299:123-130.
     PubMed     Abstract available
     
     
     
223. LIMONGELLI G, Monda E, Tramonte S, Gragnano F, et al
     Prevalence and clinical significance of red flags in patients with hypertrophic cardiomyopathy.
     Int J Cardiol. 2020;299:186-191.
     PubMed     Abstract available
     
     
     
224. SHAMSUDEEN I, Fei LYN, Burwash IG, Beauchesne L, et al
     Presentation and management of calcific mitral valve disease.
     Int J Cardiol. 2020 Jan 11. pii: S0167-5273(19)35036.
     PubMed     Abstract available
     
     
     
225. YANG L, Wu D, Li M, Zhu X, et al
     Upregulation of microRNA-195 ameliorates calcific aortic valve disease by inhibiting VWF via suppression of the p38-MAPK signaling pathway.
     Int J Cardiol. 2020 Jan 8. pii: S0167-5273(19)33810.
     PubMed     Abstract available
     
     
     December 2019
226. DE RONDE-TILLMANS MJAG, Goudzwaard JA, El Faquir N, van Mieghem NM, et al
     TAVI Care and Cure, the Rotterdam multidisciplinary program for patients undergoing transcatheter aortic valve implantation: Design and rationale.
     Int J Cardiol. 2019 Dec 16. pii: S0167-5273(19)30407.
     PubMed     Abstract available
     
     
     November 2019
227. BEN-ASSA E, Biner S, Elmariah S, Banai S, et al
     Author's reply to: Worsening of mitral regurgitation following transcatheter aortic valve replacement.
     Int J Cardiol. 2019 Nov 30. pii: S0167-5273(19)34780.
     PubMed    
     
     
     
228. SAEED S, Mancia G, Rajani R, Parkin D, et al
     Sex-differences in aortic stenosis: Effect on functional capacity and prognosis.
     Int J Cardiol. 2019 Nov 28. pii: S0167-5273(19)34571.
     PubMed     Abstract available
     
     
     
229. PAPARELLA D, Fattouch K, Moscarelli M, Santarpino G, et al
     Current trends in mitral valve surgery: A multicenter national comparison between full-sternotomy and minimally-invasive approach.
     Int J Cardiol. 2019 Nov 26. pii: S0167-5273(19)35541.
     PubMed     Abstract available
     
     
     
230. SEOUDY H, Kuhn C, Frank J, Eden M, et al
     Prognostic implications of N-terminal pro-B-type natriuretic peptide in patients with normal left ventricular ejection fraction undergoing transcatheter aortic valve implantation.
     Int J Cardiol. 2019 Nov 12. pii: S0167-5273(19)32508.
     PubMed     Abstract available
     
     
     October 2019
231. WOITEK FJ, Stachel G, Kiefer P, Haussig S, et al
     Treatment of failed aortic bioprostheses: An evaluation of conventional redo surgery and transfemoral transcatheter aortic valve-in-valve implantation.
     Int J Cardiol. 2019 Oct 31. pii: S0167-5273(19)32470.
     PubMed     Abstract available
     
     
     
232. KIM WK, Hamm CW
     TAVR for mixed aortic valve disease - A good companionship?
     Int J Cardiol. 2019 Oct 25. pii: S0167-5273(19)33870.
     PubMed    
     
     
     
233. SPACCAROTELLA C, Mongiardo A, Sorrentino S, Indolfi C, et al
     Which hospital should be selected for readmission after TAVR?
     Int J Cardiol. 2019;293:107-108.
     PubMed    
     
     
     
234. MUIESAN ML, Paini A, Salvetti M
     Antihypertensive drugs and outcome in aortic stenosis.
     Int J Cardiol. 2019 Oct 12. pii: S0167-5273(19)34542.
     PubMed    
     
     
     
235. HAMDAN A, Kornowski R
     TAVI in bicuspid aortic valve stenosis.
     Int J Cardiol. 2019 Oct 12. pii: S0167-5273(19)34494.
     PubMed    
     
     
     
236. RUSINARU D, Rietzschel ER, Bohbot Y, De Buyzere ML, et al
     Allometric versus ratiometric normalization of left ventricular stroke volume by Doppler-echocardiography for outcome prediction in severe aortic stenosis with preserved ejection fraction.
     Int J Cardiol. 2019 Oct 9. pii: S0167-5273(19)31998.
     PubMed     Abstract available
     
     
     
237. LOSI MA, Mancusi C, Midtbo H, Saeed S, et al
     Impact of estimated left atrial volume on prognosis in patients with asymptomatic mild to moderate aortic valve stenosis.
     Int J Cardiol. 2019 Oct 3. pii: S0167-5273(18)36936.
     PubMed     Abstract available
     
     
     September 2019
238. SAEED S, Mancia G, Rajani R, Parkin D, et al
     Antihypertensive treatment with calcium channel blockers in patients with moderate or severe aortic stenosis: Relationship with all-cause mortality.
     Int J Cardiol. 2019 Sep 7. pii: S0167-5273(19)32589.
     PubMed     Abstract available
     
     
     
239. UESHIMA D, Nai Fovino L, Brener SJ, Fabris T, et al
     Transcatheter aortic valve replacement for bicuspid aortic valve stenosis with first- and new-generation bioprostheses: A systematic review and meta-analysis.
     Int J Cardiol. 2019 Sep 6. pii: S0167-5273(19)33116.
     PubMed     Abstract available
     
     
     
240. MORIS C, Avanzas P
     Long term TAVI: Only time will tell.
     Int J Cardiol. 2019;290:84-85.
     PubMed    
     
     
     August 2019
241. BORREGAARD B, Dahl JS, Riber LPS, Ekholm O, et al
     Effect of early, individualised and intensified follow-up after open heart valve surgery on unplanned cardiac hospital readmissions and all-cause mortality.
     Int J Cardiol. 2019;289:30-36.
     PubMed     Abstract available
     
     
     July 2019
242. DAYAN V, Zuasnabar A, Citro R, Bossone E, et al
     Aortopathy and regurgitation in bicuspid valve patients increase the risk of aortopathy in relatives.
     Int J Cardiol. 2019;286:117-120.
     PubMed     Abstract available
     
     
     June 2019
243. VAN DE HEYNING CM, Ammirati E
     MitraClip system as bridge to left ventricular assist device in selected patients with advanced heart failure.
     Int J Cardiol. 2019 Jun 14. pii: S0167-5273(19)31653.
     PubMed    
     
     
     May 2019
244. AMMIRATI E, Van De Heyning CM, Musca F, Brambatti M, et al
     Safety of centrifugal left ventricular assist device in patients previously treated with MitraClip system.
     Int J Cardiol. 2019;283:131-133.
     PubMed     Abstract available
     
     
     April 2019
245. JEWGENOW P, Schneider H, Bokenkamp R, Horer J, et al
     Subclinical thrombus formation in bioprosthetic pulmonary valve conduits.
     Int J Cardiol. 2019;281:113-118.
     PubMed     Abstract available
     
     
     
246. KIM WK, Brinkert M, Mangner N, Gatto F, et al
     Transfemoral implantation of the ACURATE neo prosthesis using a low-profile expandable introducer system: A multicenter registry.
     Int J Cardiol. 2019;281:76-81.
     PubMed     Abstract available
     
     
     
247. HUANG MS, Lee WH, Tsai HR, Liu YW, et al
     Value of layer-specific strain distribution patterns in hypertrophied myocardium from different etiologies.
     Int J Cardiol. 2019;281:69-75.
     PubMed     Abstract available
     
     
     
248. FERLINI M, Mauri S, Rossini R
     Dual antiplatelet therapy after TAVR: A drop in the bucket?
     Int J Cardiol. 2019;280:46-48.
     PubMed     Abstract available
     
     
     
249. EGIDY ASSENZA G, Mariucci ME, Chiarabelli M, Donti A, et al
     First-in-human, off-label use of BeGraft(R) stenting of non-conduit, large right ventricular outflow tract for transcatheter valve landing zone preparation.
     Int J Cardiol. 2019;280:43-45.
     PubMed     Abstract available
     
     
     March 2019
250. LOPES LR, Brito D, Belo A, Cardim N, et al
     Genetic characterization and genotype-phenotype associations in a large cohort of patients with hypertrophic cardiomyopathy - An ancillary study of the Portuguese registry of hypertrophic cardiomyopathy.
     Int J Cardiol. 2019;278:173-179.
     PubMed     Abstract available
     
     
     
251. DI LULLO L, Tripepi G, Ronco C, D'Arrigo G, et al
     Cardiac valve calcification and use of anticoagulants: Preliminary observation of a potentially modifiable risk factor.
     Int J Cardiol. 2019;278:243-249.
     PubMed     Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Valvular Heart Disease is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: